Bio2 Technologies (Woburn, MA) is a privately-held medical device company applying CLM?, a propriety Cross-Linked Microstructure fiber bonding process, to produce a range of biocompatible materials with broad application in musculoskeletal clinical practice. Along with offering superior mechanical and biological properties, CLM Technology allows the use of rapid, low cost component fabrication methods.

The company has a broad intellectual property and rights portfolio with both issued and pending patents pertaining to the CLM process and its application to the biomaterials field.